| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Hapvida Participações e Investimentos S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$2.67 |
| 52 Week High | R$2.67 |
| 52 Week Low | R$2.67 |
| Beta | 0.70 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| HAPV.Y | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -0.1% | -1.3% |
| 1Y | n/a | 2.1% | 30.7% |
Return vs Industry: Insufficient data to determine how HAPV.Y performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how HAPV.Y performed against the US Market.
Price Volatility
| HAPV.Y volatility | |
|---|---|
| HAPV.Y Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HAPV.Y's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine HAPV.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | n/a | Jorge Fontoura Pinheiro de Lima | ri.hapvida.com.br |
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the health sector in Brazil. The company offers medical and dental insurance plans. It also provides medical and paramedical, laboratory, diagnostic, imaging, and ultrasound services, as well as organizes courses, lectures, seminars, and other events.
Hapvida Participações e Investimentos S.A. Fundamentals Summary
| HAPV.Y fundamental statistics | |
|---|---|
| Market cap | US$4.52b |
| Earnings (TTM) | -US$95.13m |
| Revenue (TTM) | US$4.69b |
1.0x
P/S Ratio-47.6x
P/E RatioIs HAPV.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HAPV.Y income statement (TTM) | |
|---|---|
| Revenue | R$27.33b |
| Cost of Revenue | R$24.23b |
| Gross Profit | R$3.11b |
| Other Expenses | R$3.66b |
| Earnings | -R$554.63m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 12, 2024
| Earnings per share (EPS) | -0.074 |
| Gross Margin | 11.37% |
| Net Profit Margin | -2.03% |
| Debt/Equity Ratio | 24.4% |
How did HAPV.Y perform over the long term?
See historical performance and comparison